BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10374331)

  • 1. [Alterations of retinoblastoma gene and its protein expression in aggressive bone tumors].
    Li Y; Qiu J
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):262-5. PubMed ID: 10374331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alterations of MDM2 and p53 genes in bone tumors].
    Zhou X; Gao L; Zhe X
    Zhonghua Bing Li Xue Za Zhi; 1997 Oct; 26(5):270-2. PubMed ID: 10374333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP; Burns KL; Rosenberg AE; Louis DN
    Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum of the retinoblastoma gene in osteosarcomas.
    Wadayama B; Toguchida J; Shimizu T; Ishizaki K; Sasaki MS; Kotoura Y; Yamamuro T
    Cancer Res; 1994 Jun; 54(11):3042-8. PubMed ID: 8187094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors.
    Araki N; Uchida A; Kimura T; Yoshikawa H; Aoki Y; Ueda T; Takai S; Miki T; Ono K
    Clin Orthop Relat Res; 1991 Sep; (270):271-7. PubMed ID: 1884549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of RB gene in osteosarcoma by PCR].
    Li HG
    Zhonghua Wai Ke Za Zhi; 1993 Dec; 31(12):714-6. PubMed ID: 8033699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rb-loss is associated with high malignancy in chondrosarcoma.
    Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
    Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of retinoblastoma gene-mediated cell growth and tumor suppression in human cancer cells.
    Zhou Y; Li J; Xu K; Hu SX; Benedict WF; Xu HJ
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4165-9. PubMed ID: 8183886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.
    Wunder JS; Czitrom AA; Kandel R; Andrulis IL
    J Natl Cancer Inst; 1991 Feb; 83(3):194-200. PubMed ID: 1988704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of podoplanin in human bone and bone tumors: New marker of osteogenic and chondrogenic bone tumors.
    Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Umezu H; Sugai M; Endo N
    Pathol Int; 2010 Mar; 60(3):193-202. PubMed ID: 20403045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of the p53, Rb and MDM2 genes in osteosarcoma.
    Miller CW; Aslo A; Won A; Tan M; Lampkin B; Koeffler HP
    J Cancer Res Clin Oncol; 1996; 122(9):559-65. PubMed ID: 8781571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells.
    Rubio R; Abarrategi A; Garcia-Castro J; Martinez-Cruzado L; Suarez C; Tornin J; Santos L; Astudillo A; Colmenero I; Mulero F; Rosu-Myles M; Menendez P; Rodriguez R
    Stem Cells; 2014 May; 32(5):1136-48. PubMed ID: 24446210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the retinoblastoma gene product in renal tumors.
    Presti JC; Reuter VE; Cordon-Cardo C; Motzer RJ; Albino AP; Jhanwar SC; Nanus DM
    Anticancer Res; 1996; 16(2):549-56. PubMed ID: 8687097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reintroduction of a normal retinoblastoma gene into retinoblastoma and osteosarcoma cells inhibits the replication associated function of SV40 large T antigen.
    Uzvolgyi E; Classon M; Henriksson M; Huang HJ; Szekely L; Lee WH; Klein G; Sumegi J
    Cell Growth Differ; 1991 Jun; 2(6):297-303. PubMed ID: 2064998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUNX2 expression in developing human bones and various bone tumors.
    Sugawara M; Kato N; Tsuchiya T; Motoyama T
    Pathol Int; 2011 Oct; 61(10):565-71. PubMed ID: 21951664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.
    Toguchida J; Ishizaki K; Sasaki MS; Ikenaga M; Sugimoto M; Kotoura Y; Yamamuro T
    Cancer Res; 1988 Jul; 48(14):3939-43. PubMed ID: 2898286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [p53 antioncogene abnormal in osteosarcoma].
    Guo W; Wang SW; Feng CH
    Zhonghua Wai Ke Za Zhi; 1994 Jul; 32(7):412-5. PubMed ID: 7842979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.